Please Wait
Applying Filters...
menu
    • menu
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    AMP945

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Amplia Therapeutics Releases Q3 Activities and Cash Flow Report
    Amplia Therapeutics Releases Q3 Activities and Cash Flow Report

    30 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/30/3229545/0/en/Amplia-Therapeutics-Quarterly-Activities-and-Cash-Flow-Reports-December-2025.html

    GLOBENEWSWIRE
    30 Jan 2026
    Share Share
    Narmafotinib Large-Scale Manufacturing Complete
    Narmafotinib Large-Scale Manufacturing Complete

    22 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/22/3223746/0/en/NARMAFOTINIB-Large-Scale-Manufactre-Complete.html

    GLOBENEWSWIRE
    22 Jan 2026
    Share Share
    Amplia Therapeutics To Present At 2026 ASCO Gi Cancers Symposium
    Amplia Therapeutics To Present At 2026 ASCO Gi Cancers Symposium

    23 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/23/3209888/0/en/Amplia-Therapeutics-to-Present-at-2026-ASCO-Gastrointestinal-Cancers-Symposium.html

    GLOBENEWSWIRE
    23 Dec 2025
    Share Share
    Amplia Investor Presentation Reveal Additional Confirmed Response
    Amplia Investor Presentation Reveal Additional Confirmed Response

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204647/0/en/Additional-Confirmed-Response-Reported-as-Part-of-Amplia-Investor-Presentation.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Key Narmafotinib Patent Granted In U.S.
    Key Narmafotinib Patent Granted In U.S.

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3198906/0/en/Key-Narmafotinib-Patent-Granted-in-the-U-S.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share
    Adagene Starts Investigator-Led Ph 2 Trial of Muzastotug
    Adagene Starts Investigator-Led Ph 2 Trial of Muzastotug

    27 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/27/3033784/0/en/Adagene-Announces-Investigator-Initiated-Phase-2-Trial-for-Neoadjuvant-Muzastotug-ADG126-in-Colorectal-Cancer.html

    GLOBENEWSWIRE
    27 Feb 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.